Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients

被引:23
|
作者
Slimani, Afef [1 ]
Jelassi, Awatef [1 ]
Jguirim, Imen [1 ]
Najah, Mohamed [1 ]
Rebhi, Lamia [2 ]
Omezzine, Asma [2 ]
Maatouk, Faouzi [3 ]
Ben Hamda, Khaldoun [3 ]
Kacem, Maha [4 ]
Rabes, Jean-Pierre [5 ]
Abifadel, Marianne [6 ]
Boileau, Catherine [5 ,7 ]
Rouis, Mustapha [8 ]
Slimane, Mohamed Naceur [1 ]
Varret, Mathilde [7 ]
机构
[1] Fac Med, Unit Res Genet & Biol Factors Atherosclerosis, Monastir 5000, Tunisia
[2] Sahloul Univ Hosp, Dept Biochem, URMSP 28 04, Sousse, Tunisia
[3] Fattouma Bourguiba Hosp, Dept Cardiovasc Dis, Monastir 5000, Tunisia
[4] Farhat Hachad Hosp, Dept Endocrinol, Sousse, Tunisia
[5] Univ Versailles St Quentin En Yvelines, Hop A Pare, AP HP, Versailles, France
[6] Univ St Joseph, Fac Pharm, Beirut, Lebanon
[7] Univ Paris Denis Diderot, CHU Xavier Bichat, INSERM, U698, Paris, France
[8] Univ Paris 06, UMR Physiol & Physiopathol 7079, Paris, France
关键词
Familial hypercholesterolemia; LDLR gene; PCSK9; gene; Phenotypic variability; APOLIPOPROTEIN-E; CHOLESTEROL LEVELS; POLYMORPHISMS; SPECTRUM; VARIANT;
D O I
10.1016/j.atherosclerosis.2012.02.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Autosomal dominant hypercholesterolemia (ADH) is commonly caused by mutations in the low-density lipoprotein (LDL) receptor gene (LDLR), in the apolipoprotein B-100 gene (APOB), or in the proprotein convertase subtilisin kexine 9 gene (PCSK9). ADH subjects carrying a mutation in LDLR present highly variable plasma LDL-cholesterol (LDL-C). This variability might be due to environmental factors or the effect of some modifying genes such as PCSK9 and APOE. Aims: We investigated the molecular basis of thirteen Tunisian ADH families and attempted to determine the impact of PCSK9 and APOE gene variations on LDL-cholesterol levels and on the variable phenotypic expression of the disease. Methods and results: Fifty six subjects were screened for mutations in the LDLR gene through direct sequencing. The causative mutation was found to segregate with the disease in each family and a new frameshift mutation, p.Met767CysfsX21, was identified in one family. The distribution of total-and LDL-cholesterol levels, adjusted for age and gender, among homozygous and heterozygous ADH patients varied widely. Within seven families, nine subjects presented low LDL-cholesterol levels despite carrying a mutation in the LDLR gene. To identify the molecular actors underlying this phenotypic variability, the PCSK9 gene was screened using direct sequencing and/or enzymatic restriction analysis, and the apo E genotypes were determined. A new missense variation (p.Pro174Ser) in the PCSK9 gene was identified and characterized as a new putative loss-of-function mutation. Conclusion: Genetic variations in PCSK9 and APOE genes could explain only part of the variability observed in the phenotypic expression in Tunisian ADH patients carrying mutations in the LDLR gene. Other genetic variants and environmental factors very probably act to fully explain this phenotypic variability. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:158 / 166
页数:9
相关论文
共 50 条
  • [41] PCSK9 in South African Variants of Familial Hypercholesterolemia
    Getz, Godfrey S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (22) : 2374 - 2375
  • [42] A CASE FOR PCSK9 INHIBITORS IN A PATIENT WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Arnold, Claire
    Stephenson, Christopher
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S574 - S575
  • [43] Getting Real With PCSK9 Inhibitors in Familial Hypercholesterolemia
    Baass, Alexis
    Hegele, Robert A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (08) : 959 - 961
  • [44] Familial hypercholesterolemia: Is there a role for PCSK9 and thrombin generation?
    Silvino, J. P. P. .
    Carvalho, M. G.
    Reis, E. A.
    Mota, A. P. L.
    Gomes, K. B.
    Duarte, R. C. F.
    Guimaraes, M. C. J.
    Sousa, M. C. R.
    Azevedo, P. S.
    Silva, I. F. O.
    THROMBOSIS RESEARCH, 2021, 200 : 156 - 163
  • [45] Structural and Molecular Interaction Studies on Familial Hypercholesterolemia Causative PCSK9 Functional Domain Mutations Reveals Binding Affinity Alterations with LDLR
    Zuhier Ahmed Awan
    Rawabi Bahattab
    Hussam Ibrahim Kutbi
    Ahmad Omar Jamal Noor
    Marzog S. Al-Nasser
    Noor Ahmad Shaik
    Babajan Banaganapalli
    International Journal of Peptide Research and Therapeutics, 2021, 27 : 719 - 733
  • [46] Structural and Molecular Interaction Studies on Familial Hypercholesterolemia Causative PCSK9 Functional Domain Mutations Reveals Binding Affinity Alterations with LDLR
    Awan, Zuhier Ahmed
    Bahattab, Rawabi
    Kutbi, Hussam Ibrahim
    Noor, Ahmad Omar Jamal
    Al-Nasser, Marzog S.
    Shaik, Noor Ahmad
    Banaganapalli, Babajan
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2021, 27 (01) : 719 - 733
  • [47] Identification and molecular characterization of new PCSK9 missense mutations associated with familial hypercholesterolemia
    Homer, Vivienne
    Marais, David
    Laurie, Andrew
    Charlton, Francesca
    Sullivan, David
    Barter, Philip
    Rye, Kerry-Anne
    George, Peter
    Lambert, Gilles
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E122 - E122
  • [48] PROPROTEIN CONVERTASE SUBTILISIN/KEXIN 9 (PCSK9) V4I VARIANT WITH LDLR MUTATIONS MODIFIES THE PHENOTYPE OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Hori, M.
    Ohta, N.
    Takahashi, A.
    Ogura, M.
    Makino, H.
    Tamanaha, T.
    Miyamoto, Y.
    Harada-Shiba, M.
    ATHEROSCLEROSIS, 2016, 252 : E35 - E36
  • [49] Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis
    Chora, Joana Rita
    Medeiros, Ana Margarida
    Alves, Ana Catarina
    Bourbon, Mafalda
    GENETICS IN MEDICINE, 2018, 20 (06) : 591 - 598
  • [50] Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
    Marianne Abifadel
    Mathilde Varret
    Jean-Pierre Rabès
    Delphine Allard
    Khadija Ouguerram
    Martine Devillers
    Corinne Cruaud
    Suzanne Benjannet
    Louise Wickham
    Danièle Erlich
    Aurélie Derré
    Ludovic Villéger
    Michel Farnier
    Isabel Beucler
    Eric Bruckert
    Jean Chambaz
    Bernard Chanu
    Jean-Michel Lecerf
    Gerald Luc
    Philippe Moulin
    Jean Weissenbach
    Annick Prat
    Michel Krempf
    Claudine Junien
    Nabil G Seidah
    Catherine Boileau
    Nature Genetics, 2003, 34 : 154 - 156